- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Mayo Clinic - Arizona Scottsdale, Arizona, United States
- David Geffen School of Medicine at UCLA Los Angeles, California, United States
- University of California Irvine Medical Center Orange, California, United States
- University of California (UC) Davis Sacramento, California, United States
Clinical trial condition
Diffuse Large B-Cell Lymphoma (DLBCL)
Explore clinical trials studying Diffuse Large B-Cell Lymphoma (DLBCL). Study availability and eligibility vary by location and protocol.
46 public trials
20 recruiting studies
Diffuse Large B-Cell Lymphoma (DLBCL) trial results
Recruiting
A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies
NCT07609862
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +32 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, China
Recruiting
The CARDIOPROTECT Trial
NCT07654426
- Conditions
- Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +18 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT07494565
- Conditions
- CD5 Positive, Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Recruiting
Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms
NCT06043011
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +34 more
- Locations
-
- Praxis für Interdisziplinäre Hämatologie und Onkologie Freiburg im Breisgau, Germany
NCT04836507
- Conditions
- ALL (Acute B-Lymphoblastic Leukemia), Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, +15 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
- The Catholic University of Korea Seoul St. Mary's Hospital Seoul, South Korea
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Jiangsu Province Hospital Nanjing, Jiangsu, China
Recruiting
NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19)
NCT07502118
- Conditions
- Burkitt Lymphoma, Cytokine Release Syndrome, DNA Virus Infections, +29 more
- Locations
-
- Ankara Bilkent City Hospital - Hematology Clinic Ankara, Turkey (Türkiye)
- Ankara Etlik City Hospital - Hematology Clinic Ankara, Turkey (Türkiye)
- Hacettepe University Faculty of Medicine - Department of Internal Medicine, Division of Hematology Ankara, Turkey (Türkiye)
- University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Ankara, Turkey (Türkiye)
NCT07499271
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT07493148
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- The First Bethune Hospital of Jilin University Changchun, Jilin, China